文献詳細
特集 EDをあなどるなかれ─知っておきたい最近の話題
文献概要
▶ポイント
・PDE5阻害薬はED治療の第一選択である.どのPDE5阻害薬も同様の効果と安全性をもつが,薬物動態に違いがある.
・第二選択は陰茎海綿体注射と陰圧式勃起補助具,第三選択に陰茎プロステーシスがある.
・近年,体外衝撃波療法や局所クリームが開発され注目されている.
・PDE5阻害薬はED治療の第一選択である.どのPDE5阻害薬も同様の効果と安全性をもつが,薬物動態に違いがある.
・第二選択は陰茎海綿体注射と陰圧式勃起補助具,第三選択に陰茎プロステーシスがある.
・近年,体外衝撃波療法や局所クリームが開発され注目されている.
参考文献
1) 日本性機能学会ED診療ガイドライン2012年版作成委員会 (編) : ED診療ガイドライン2012年版. p63, リッチヒルメディカル, 東京, 2012
2) Hatzimouratidis K, Salonia A, Adaikan G, et al : Pharmacotherapy for Erectile Dysfunction : Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med 13 : 465─488, 2016
3) Kawanishi Y, Lee KS, Kimura K, et al : Feasibility of multi-slice computed tomography in the diagnosis of arteriogenic erectile dysfunction. BJU Int 88 : 390─395, 2001
4) Li WQ, Qureshi AA, Robinson KC, et al : Sildenafil use and increased risk of incident melanoma in US men : a prospective cohort study. JAMA Intern Med 174 : 964─970, 2014
5) Loeb S, Folkvaljon Y, Lambe M, et al : Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma. JAMA 313 : 2449─2455, 2015
6) Lian Y, Yin H, Pollak MN, et al : Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer. Eur Urol 2016 [Epub ahead of print]
7) Matthews A, Langan SM, Douglas IJ, et al : Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma : Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink. PLoS Med 13 : e1002037, 2016
8) Dell'Atti L : Efficacy of Tadalafil once daily versus Fesoterodine in the treatment of overactive bladder in older patients. Eur Rev Med Pharmacol Sci 19 : 1559─1563, 2015
9) Corvasce A, Albino G, Leonetti T, et al : Once-a-day Tadalafil administration improves the spermogram parameters in fertile patients. Arch Ital Urol Androl 87 : 210─213, 2015
10) Belew D, Klaassen Z and Lewis RW : Intracavernosal injection for the diagnosis, evaluation, and treatment of erectile dysfunction : A review. Sex Med Rev 3 : 11─23, 2015
11) He L, Wen J, Jiang X, et al : Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China. Andrologia 43 : 208─212, 2011
12) Vardi Y, Appel B, Kilchevsky A, et al : Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study. J Urol 187 : 1769─1775, 2012
13) Hisasue S, China T, Horiuchi A, et al : Impact of aging and comorbidity on the efficacy of low-intensity shock wave therapy for erectile dysfunction. Int J Urol 23 : 80─84, 2016
14) Porst H, Burnett A, Brock G, et al : SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med 10 : 130─171, 2013
15) Rooney M, Pfister W, Mahoney M, et al : Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction. J Sex Med 6 : 520─534, 2009
16) Montorsi F, Rigatti P, Carmignani G, et al : AMS three-piece inflatable implants for erectile dysfunction : a long-term multiinstitutional study in 200 consecutive patients. Eur Urol 37 : 50─55, 2000
17) Deveci S, Martin D, Parker M, et al : Penile length alterations following penile prosthesis surgery. Eur Urol 51 : 1128─1131, 2007
掲載誌情報